Matthias Stelljes

University of Münster — Germany

Medicine · Health Sciences

59h-index16.2kcitations523works6.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(234), Acute Myeloid Leukemia Research(226), Hematopoietic Stem Cell Transplantation(210), Chronic Myeloid Leukemia Treatments(130), CAR-T cell therapy research(90)

Publications521 total

Relapse after allogeneic hematopoietic stem cell transplantation in patients with active acute myeloid leukemia
Leukemia Research·2025Open Access
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial
Blood·2025
Outcomes of people living with acute lymphoblastic leukemia who received inotuzumab ozogamicin before a stem cell transplant: a plain language summary
Future Oncology·2025Open Access
Reduced intensity conditioning with 8 Gy total body irradiation in adult patients with acute lymphoblastic leukemia
Bone Marrow Transplantation·2025Open Access
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with cardiovascular comorbidity undergoing allogeneic hematopoietic cell transplantation for acute myeloid leukaemia in first complete remission from unrelated donors: a retrospective matched-pair analysis from the ALWP of the EBMT
Bone Marrow Transplantation·2025Open Access
Pretransplantation Hypomethylating Agents and Venetoclax in Acute Myeloid Leukemia Patients: A Real-World Analysis from the Cooperative Transplant Study Group
Transplantation and Cellular Therapy·2025Open Access
Impact of donor selection in adverse-risk AML undergoing hematopoietic cell transplantation: A study from the EBMT Acute Leukemia Working Party
Bone Marrow Transplantation·2025
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT
Bone Marrow Transplantation·2025
Impact of European LeukemiaNet–guided postremission therapy on outcomes of patients with AML from 2010 to 2022
Blood Neoplasia·2025Open Access
Effect of FLT3 maintenance in older FLT3-ITD+ adults undergoing allogeneic HCT. a post hoc analysis of BMT CTN 1506
Blood·2025
Outcomes of autologous hematopoietic stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A registry-based study from the EBMT-LWP
Blood·2025
Better outcomes with haploidentical than matched sibling donors for adult AML patients allo-transplanted in CR with detectable MRD: A study from the global committee and the ALWP of the EBMT.
Blood·2025Open Access
Multicenter Phase II trial of enasidenib as maintenance treatment following allogeneic stem cell transplantation in IDH2-mutated myeloid neoplasms – the IDH2-post-allo-trial (NCT04522895)
Blood·2025Open Access
Ruxolitinib versus allogeneic stem cell transplantation for patients with myelofibrosis according to donor availability: A prospective multicenter phase II trial
Blood·2025Open Access
Time from AML diagnosis to HCT and pre-HCT FLT3 inhibition impact pre-transplant MRD and benefit from post-HCT gilteritinib
Blood·2025Open Access
Matched unrelated vs. Haploidentical  donor for allogeneic stem cell transplantation in patients with acute leukemia with identical GvHD prophylaxis – a randomized prospective european trial.
Blood·2025
Allogeneic hematopoietic cell transplantation in TP53-mutated Acute Myeloid Leukemia patients with active disease: A study from the global committee and the acute leukemia working party of the EBMT
Blood·2025
Impact of NRAS and/or KRAS mutations on post-transplant outcomes in Acute Myeloid Leukemia: A study on behalf of EBMT-ALWP
Blood·2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Bone Marrow Transplantation·2025Open Access
Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in Remission
Transplantation and Cellular Therapy·2025Open Access
page 1 of 27Next →

Frequent Co-authors

Martin Bornhäuser(15), Nicola Gökbuget(14), Gerhard Ehninger(12), Hubert Serve(12), Wolfgang E. Berdel(11), Dietrich W. Beelen(11), Andreas Viardot(10), Wolfgang Bethge(10), Dieter Hoelzer(9), Gerhard Zugmaier(9), Nicolaus Kröger(9), Monika Brüggemann(8), Hermann Einsele(8), Ralf C. Bargou(8), Christian Thiede(8), Johannes Schetelig(8), Matthias Klinger(7), Svenja Neumann(7), Max S. Topp(7), Albrecht Reichle(7)